Fat jab price soars after Trump threat: Cost of Mounjaro up 170% as US President demands UK pay more

Donald Trump ‘King Kong’ Fat Jab Mounjaro’s cost will almost double in England after a global drug price war.

Manufacturer Lilly, from next month onwards, the wholesale price ‘other developed countries’ plans to make the same line, he said.

Movement, Mounjaro’s annual cost for users who pay specially for the highest dose of the current dose.

Pharmacy leaders are afraid that more companies will now be encouraged to announce their own price increases – and they will face the risk of being a ‘pawn’ in a wider dispute of patients’ cost of drugs.

The increase in inflation comes after President Trump demands lower prices for US drug producers, which he calls ‘health services of foreign countries Sübsanse et’.

In a letter to pharmaceutical companies, ‘more negotiating with foreign -free countries’ and ‘increasing revenues abroad should be sent back to lower drug prices for American patients and taxpayers’.

Mr. Trump complained that a friend had previously bought a ‘fat drug’ in London for a part of the US cost in the US, although the same box made by the same company at the same facility ‘.

He wants companies to guarantee that US patients have collected the best possible price for other developed countries for equal or better drugs, and said companies to earn any income from other nations.

Pharmacy leaders are afraid that more companies will now be encouraged to announce their own price increases – and they will face the risk of being a ‘pawn’ in a wider dispute of patients’ cost of drugs. (File picture)

Dr Leyla Hannbeck, General Manager of Independent Pharmacists Association, representing thousands of community pharmacies in the UK, said: ‘We were more shocked and frustrated than Mounjaro’s wholesale costs.

‘This is a real blow to patients, at a time when more people turn to jabs about their weight.

“British patients should not become a pawn in a wider dispute about the costs of president Trump’s latest letter to US drug producers.”

The list price of 15 mg KWikpen, which is the highest dose and sufficient for four shots per week, will rise from £ 122 to £ 330, with an increase of 170 percent. Some online retailers already get more wages.

The US company Eli Lilly said that the cost of a 2.5 mg pen, which is the lowest dose, will rise from September 1 to £ 92 to £ 133. Clinical research on the effectiveness of injections shows that they provide ‘value’.

Studies have shown that patients with active drugs in Mounjaro lost 20 percent of their body weight for 72 weeks.

Mounjaro, especially compared to certain competitors, was nicknamed King Kong of weight loss drugs due to strong consequences in clinical studies.

Lilly negotiates separately with special providers who can provide a discount to customers.

Dr Leyla Hannbeck, General Manager of Independent Pharmacists Association, said, ‘British patients should not become a pawn in a wider dispute about the costs of drugs caused by President Trump (in the picture) to US drug producers.

Studies have shown that patients with active drugs in Mounjaro lost 20 percent of their body weight for 72 weeks. Mounjaro was nicknamed King Kong of weight loss drugs due to its strong consequences (file image) in clinical studies.

However, the company said that it is dependent on pharmacies and that it may include processing fees and consultation fees. The price paid by NHS will not change.

Dr Hannbeck added: ‘IPA invites other weight loss manufacturers to hold their nerves and keep their prices.

British weight loss JABS market is only set to growth, but this will only be achieved if the treatment remains appropriate to the average patient. ‘

‘We are worried that more pharmaceutical companies may increase their prices due to tariffs, and we are worried that this will have a harmful effect on our pharmaceutical market, pharmacies and patients.

We call on the government to be unexpected situations in case of this. ‘

The United Kingdom government closely monitors and develops with the price of global drugs and will try to protect the materials and NHS.

Online pharmacies around the world were receiving very different prices for the £ 199 in the UK, £ 331 in Australia, £ 421 in Germany and £ 813 in the United States.

JAB works by targeting the GLP-1 receptors that suppress appetite and make users feel fuller for a longer time.

Online pharmacies around the world were receiving very different prices for the £ 199 in the UK, £ 331 in Australia, £ 421 in Germany and £ 813 in the United States. JAB works by targeting GLP-1 receptors

Famous users had an increase in popularity, and NHS had a global GLP-1 injection shortage after warning individuals against unauthorized resources.

A Lilly spokesman said: ‘After a review, Lilly will increase the price of the UK for Mounjaro (Tyrzipathide) to address price inconsistencies compared to other developed countries, including Europe.

‘In parallel, we reached an agreement with NHS to ensure supply and patient access. Although Lilly does not determine the prices determined by private health service providers, we work with them to maintain patient access.

‘England was one of the first countries Lilly started Mounjaro, and our priority was to bring patients as quickly as possible during a limited source of GLP-1 RA treatments for Type 2 diabetes.

In order to prevent delays in Lilly, Lilly, NHS existence, a UK list is significantly below the European average.

‘With the changes in the environment and new clinical evidence that supports Mounjaro’s value, we are now aligning the list price more consistently to make fair global contributions to the cost of innovation.’

Two of the three adults in Britain are obese or overweight and more than 5 million people are connected to weak diet and lifestyle. Estimates show that one of ten women already gets weight loss jabs (file picture)

Two of the three adults in Britain are obese or overweight and more than 5 million people are connected to weak diet and lifestyle.

Estimates show that one of the ten women already has already received weight loss jabs.

A NHS UK spokesman said: ‘Licensed, cost -effective weight loss medication, such as Tirzepathide (Mounjaro), provides a valuable tool to support the access to a health and lifestyle that offers a healthier weight and a healthier weight.

‘List price increase will not affect the commissioning of Tirmidin NHS in the UK for appropriate people who live with obesity based on clinical priority or as type 2 diabetes treatment. Anyone who has questions about special thyrzepathide prescriptions should contact the providers. ‘